Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Transferases
Patent
1994-04-11
1997-11-25
Walsh, Stephen
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Transferases
435 697, 514 12, 530412, 530413, 530418, A61K 3845
Patent
active
056909284
ABSTRACT:
Methods and compositions for treating bladder cancer using TGF-alpha or EGF fused to PE.sub.40 or cysteine modified derivatives are taught. Also, a method of producing TGF-alpha-PE.sub.40 derivatives of enhanced potency is described.
REFERENCES:
patent: 4518584 (1985-05-01), Mark et al.
patent: 4545985 (1985-10-01), Pastan et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4675382 (1987-06-01), Murphy et al.
patent: 4742003 (1988-05-01), Derynck et al.
patent: 4892827 (1990-01-01), Pastan et al.
Allured, V.S. et al., Structure of exototoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution, (1985), Proc. Natl. Acad. Sci. (Biophysics), 83, pp. 1320-1324.
Berger, M.S. et al., Biological Abstract AB. #85069842 (1987).
Chaudhary, V.K. et al., Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity, (1990), Proc. Natl. Acad. Sci. (Biochemistry), 87, pp. 308-312.
Chaudhary, V.K. et al., Role of domain II of Pseudomonas exotoxin in the secretion of proteins into the periplasm and medium by Escherichia coli, (1988), Proc. Natl. Acad. Sci. (Biochemistry), 85, pp. 2939-2943.
Chaudhary, V.K. et al., Activity of a recombinant fusion protein between transforming growth factor type a and Pseudomonas toxin, (1987), Proc. Natl. Acad. Sci. (Genetics), 84, pp. 4538-4542.
Edwards, G.M. et al., Epidermal Growth Factor Receptor Binding Is Affected by Structural Determinants in the Toxin Domain of Transforming Growth Factor-Alpha-Pseudomonas Exotoxin Fusion Proteins, (1989), Molecular and Cellular Biology, 9, No. 7, pp. 2860-2867.
Gusterson, B. et al., Evidence for Increased Epidermal Growth Factor Receptors in Human Sarcomas, (1985), Int. J. Cancer, 36, pp. 689-693.
Heimbrook, D.C. et al., Transforming Growth factor a-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts, (1990), Proc. Natl. Acad. Sci. (Med. Sciences), 87, pp. 4697-4701.
Hwang, J. et al., Functional Domains of Pseudomonas Exotoxin Identified by Deletion Analysis of the Gene Expressed in E. coli, (1987), Cell, 48, pp. 129-136.
Jinno, Y. et al., Domain II Mutants of Pseudomonas Exotoxin Deficient in Translocation, (1989), J. Biol. Chem., 17, pp. 15953-15959.
Madshus, I.H. et al., Effects of Eliminating a Disulfide Bridge within Domain II of Pseudomonas aeruginosa Exotoxin A, (1989), Infection and Immunity, 57, No. 7, pp. 1873-1878.
Murphy, J.R. et al., Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related a-melanocyte-stimulating hormone fusion protein, (1986), Proc. Natl. Acad. Sci. (Genetics), 83, pp. 8258-8262.
Neal, D.E. et al., Epidermal-Growth-Factor Receptors in Human Bladder Cancer: Comparison of Invasive and Superficial Tumours, (Feb. 16, 1985), The Lancet, 1(8425), pp. 366-368.
Pai, L.H. et al., Antitumor Activity of a Transforming Growth Factor a-Pseudomonas Exotoxin Fusion Protein (TGF-a-PE40), (1991), Cancer Research, 51, pp. 2808-2812.
Pastan, I. and FitzGerald, D., Pseudomonas Exotoxin: Chimeric Toxins, (1989), J. Biol. Chem., 264, pp. 15157-15160.
Raghavan, D. et al., Biology and Management of Bladder Cancer, (1990), New England J. Med., 322, No. 16, pp. 1129-1138.
Sherwin, S.A. et al., High-Molecular Weight Transforming Growth Factor Activity in the Urine of Patients with Disseminated Cancer, (1983), Cancer Research, 43, pp. 403-407.
Siegall, C.B. et al., Functional Analysis of Domains II, Ib, and III of Pseudomonas Exotoxin, (1989), J. Biol. Chem., 264, No. 24, pp. 14256-14261.
Spooner, R.A. and Lord, J. M., Immunotoxins: status and prospects, (1990), Tibtech, 8, pp. 189-193.
Todaro, G.J. et al., Transforming growth factors produced by certain human tumor cells: Polypeptides that interact with epidermal growth factor receptors, (1980), Proc. Natl. Acad. Sci. (Cell Biol.), 77, No. 9, pp. 5258-5262.
Winter, G. et al., Redesigning enzyme structure by site-directed mutagenesis: tyrosyl tRNA synthetase and ATP binding, (1982), Nature, 299, pp. 756-758.
Schulz et al, pp. 14-16 in Principles of Protein Structure, Springer-Verlag (NY) (1979).
Ahern Janet
Heimbrook David C.
Oliff Allen I.
Stirdivant Steven M.
Brown Karen E.
Daniel Mark R.
Merck & Co. , Inc.
Muthard David A.
Walsh Stephen
LandOfFree
Method of treating bladder cancer cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating bladder cancer cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating bladder cancer cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2104406